Accordingly, the Drug Administration of Vietnam fined Ba Dinh Biotech Pharmaceutical Joint Stock Company (located in Que Vo Industrial Park in Que Vo District of the northern province of Bac Ninh) VND150 million (approx. $6,574) for producing low-quality Misoprostol tablets.
The company is also deprived from the certificate of satisfying drug-trading requirements, issued by the Ministry of Health, in 3 months. The company is to cooperate with related bodies to withdraw and then destroy all the batch of mentioned
The company to be fined this time is USAPHA Pharmaceutical Joint Stock Company (located in Tien Son Industrial Park in Tien Du District of Bac Ninh Province). It is fined VND40 million ($1,753) for manufacturing products which are not medicine in the drug production line. The company is also deprived from the certificate of satisfying drug-trading requirements, issued by the Ministry of Health, in 4.5 months
The company is to cooperate with related bodies to withdraw its Livganic, and then send a sample of the mentioned product to any Good Laboratory Practice (GLP)-qualified organizations in the country for examination and report.
The last company to be fined by the Drug Administration of Vietnam is L-Beauty Vietnam Co. Ltd. (located at Stall 17-02 B on Floor 17 of Vincom Center Dong Khoi in District 1 of Ho Chi Minh City). It is fined VND85 million ($3,726) for trading ‘Dior Homme Sport very cool spray fresh eau de toillete’ and ‘Dior J’Adore L’or Essence de Parfum’, which do not have matching ingredients with what have been approved. It is also fined because of running a disapproved advertisement.
